[ad_1]
The WHO issued an important statement on the anniversary of China’s notification to the WHO that a mysterious respiratory disease of unknown origin was detected in Wuhan.
In a written statement made by the organization hours before the end of 2020, the Turkish scientist Prof. Dr. It was reported that the biotechnology company BioNTech, of which Uğur Şahin is a founding partner, was approved for the emergency use of the vaccine. Kovid-19 developed in cooperation with the American pharmaceutical company Pfizer.
‘A VERY POSITIVE STEP’
WHO Deputy Director General Dr. Mariangela Simao said in a statement on the matter “This is a very positive step towards global access to Covid-19 vaccines.” found the evaluation.
Simao emphasized that a great global effort is needed to distribute vaccines equally to all countries of the world.
Stating that WHO and its partners “are working around the clock to evaluate other vaccines that meet safety and efficacy standards,” Simao stressed that ensuring the supply of critical vaccines for all countries is vital to ending the epidemic. .
Pfizer and BioNTech had agreements with the US, the European Union (EU), the UK, Canada and Japan for the supply of vaccines. The US government agrees to pay $ 1.95 billion to buy 100 million doses of vaccine if the candidate is successful, while the EU has prior contracts to buy 300 million doses, the UK 40 million doses, Canada 20 million doses and Japan 120 million doses. had signed.
The company plans to produce about 1.3 billion doses of the vaccine by the end of 2021.
